Elevated Serum Sodium at Hospital Admission for SARS-CoV-2 May Indicate Increased Risk for Severe Diseases and Mortality
Serum sodium may be an effective risk stratification marker for severe illness with SARS-CoV-2. These findings, from a retrospective longitudinal cohort study, were published in the Journal of Clinical Endocrinology and Metabolism. ...
FDA approves weight management drug for patients aged 12 and older
The U.S. Food and Drug Administration has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older who are obese, as defined by specific body mass index (BMI) cut-offs for age and sex that correspond to a BMI 30 kg/m2 or higher for adults,...
Sodium zirconium cyclosilicate – take a quiz
PARSABIV (etelcalcetide)
Adverse reactions reported in ≥ 5% of Parsabiv®-treated patients1 Combined placebo-controlled substances *Included adverse reactions reported with at least 1% greater incidence in the Parsabiv® group compared to the placebo group. †Asymptomatic reductions in...
LOKELMA® (sodium zirconium cyclosilicate)
IMPORTANT SAFETY INFORMATION FOR LOKELMA® (sodium zirconium cyclosilicate) WARNINGS AND PRECAUTIONS: Gastrointestinal Adverse Events in Patients with Motility Disorders: Avoid LOKELMA in patients with severe constipation, bowel obstruction or impaction, including abnormal...
Voclosporin Granted Priority Review for Lupus Nephritis
<pre></pre> The Food and Drug Administration (FDA) will give Priority Review...
Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF
FROM ESC HEART FAILURE 2020 The DAPA-HF trial has already changed cardiology in opening up a new class of drugs to patients with heart failure (HF), whether or not they have diabetes. Now the trial is yielding clues as to how it benefits them. For now, it’s doing so by...
Kidney Stones Linked to Elevated Glucose in Men
<pre></pre> Elevated blood glucose levels, even within the nondiabetic range, are associated with an increased risk of kidney stones...